SCHEMBL30825676

SCHEMBL30825676

Cc1nc(-c2cnc(NC(C)C)n(C)c2=O)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 5/20 0.54
▸ PDGFRB P09619 3/20 0.54
▸ PDGFRA P16234 3/20 0.54
▸ LCK P06239 1/20 0.54
▸ KIT P10721 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ FLT3 P36888 1/20 0.54
▸ PTK6 Q13882 1/20 0.54
▸ KDR P35968 1/20 0.36
▸ FGFR1 P11362 1/20 0.35
▸ DHODH Q02127 1/20 0.34
▸ IDO1 P14902 1/20 0.33
▸ PDE4B Q07343 2/20 0.32
▸ PDE7A Q13946 2/20 0.32
▸ SYK P43405 4/20 0.32
▸ TYR P14679 1/20 0.32
▸ WEE1 P30291 2/20 0.31
▸ CDK4 P11802 1/20 0.30
▸ CCND1 P24385 1/20 0.30
▸ CCND2 P30279 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29222872 1.00 CSF1R (0.54) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL21872971 0.84 CSF1R (0.53) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25911644 0.82 CSF1R (0.47) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25912094 0.81 CSF1R (0.43) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25911603 0.81 CSF1R (0.48) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25317059 0.79 PDGFRB (0.47) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25319475 0.79 CSF1R (0.47) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25911369 0.79 CSF1R (0.45) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25912095 0.77 LCK (0.42) CSF1RPDGFRBPDGFRALCKKIT
SCHEMBL25911715 0.75 CSF1R (0.43) CSF1RPDGFRBPDGFRALCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117624132-A Preparation method of CSF-1R kinase inhibitor Vimseltinib (DCC-3014) 上海相辉医药科技有限公司 2024-03-01 — — CN disclosed
Send feedback